TCR2 Therapeutics Inc.
Records under this name other than the patents TCR2 Therapeutics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
Showing 1 to 3 of 3 · Back to TCR2 Therapeutics Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,377,638 | Compositions and Methods for TCR Reprogramming Using Fusion Proteins Lapsed on the fee record Ended Jul 5, 2026 · High confidence | Lapsed on the fee record | Ended Jul 5, 2026 | High confidence |
| US 11,242,376 | Compositions and Methods for TCR Reprogramming Using Fusion Proteins Lapsed on the fee record Ended Feb 8, 2026 · High confidence | Lapsed on the fee record | Ended Feb 8, 2026 | High confidence |
| US 11,085,021 | Compositions and Methods for TCR Reprogramming Using Fusion Proteins Lapsed on the fee record Ended Aug 10, 2025 · High confidence | Lapsed on the fee record | Ended Aug 10, 2025 | High confidence |